Eudaimonia Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $355K | Sell |
12,809
-1,641
| -11% | -$45.5K | 0.08% | 181 |
|
|
2023
Q4 | $416K | Sell |
14,450
-12,072
| -46% | -$348K | 0.11% | 156 |
|
|
2023
Q3 | $880K | Sell |
26,522
-1,067
| -4% | -$35.4K | 0.21% | 106 |
|
|
2023
Q2 | $1.01M | Sell |
27,589
-557
| -2% | -$20.4K | 0.23% | 109 |
|
|
2023
Q1 | $1.15M | Sell |
28,146
-1,715
| -6% | -$70K | 0.28% | 95 |
|
|
2022
Q4 | $1.53M | Sell |
29,861
-3,227
| -10% | -$165K | 0.38% | 67 |
|
|
2022
Q3 | $1.45M | Sell |
33,088
-44,443
| -57% | -$1.94M | 0.38% | 66 |
|
|
2022
Q2 | $4.07M | Buy |
77,531
+897
| +1% | +$47K | 0.75% | 28 |
|
|
2022
Q1 | $3.97M | Buy |
+76,634
| New | +$3.97M | 0.67% | 31 |
|
|
2021
Q3 | $3.06M | Sell |
71,068
-2,165
| -3% | -$93.1K | 0.55% | 42 |
|
|
2021
Q2 | $2.87M | Buy |
73,233
+6,224
| +9% | +$244K | 0.54% | 48 |
|
|
2021
Q1 | $2.43M | Buy |
67,009
+728
| +1% | +$26.4K | 0.5% | 48 |
|
|
2020
Q4 | $2.44M | Sell |
66,281
-3,861
| -6% | -$142K | 0.55% | 47 |
|
|
2020
Q3 | $2.44M | Buy |
70,142
+573
| +0.8% | +$19.9K | 0.63% | 41 |
|
|
2020
Q2 | $2.16M | Sell |
69,569
-2,906
| -4% | -$90.1K | 0.82% | 28 |
|
|
2020
Q1 | $2.24M | Buy |
72,475
+4,500
| +7% | +$139K | 0.99% | 20 |
|
|
2019
Q4 | $2.53M | Buy |
+67,975
| New | +$2.53M | 1% | 17 |
|